Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer. [electronic resource]
- Cancer Aug 1998
- 797-805 p. digital
Publication Type: Journal Article
0008-543X
Adolescent Adult Aged Antineoplastic Agents--administration & dosage Clinical Trials as Topic Dose-Response Relationship, Drug Female Humans Infusions, Intravenous--adverse effects Interleukin-2--administration & dosage Male Middle Aged Neoplasm Metastasis Neoplasms--drug therapy